> Could the AI solution be somehow misaligned by exploiting a weakness in the trial process or its math models?
Many of our institutions and cultural practices have evolved around human beings, not ruthless paperclip maximizers. Do you think the current drug approval process is bullet proof enough that a completely novel AI-generated drug candidate with zero prior research literature can be considered safe if it makes it through the process?
Tao is a mathematician. He thinks that the institutions and cultural practices in math are not up to the task of dealing with AI-generated mathematics. In software, we are finding that programming interviews, code review, testing, and many other practices are too easy to exploit by AIs, or humans augmented with AIs, and we will have to adapt too. I think it is plausible that other institutions in society will have to change for similar reasons.